JP2012521404A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521404A5
JP2012521404A5 JP2012501410A JP2012501410A JP2012521404A5 JP 2012521404 A5 JP2012521404 A5 JP 2012521404A5 JP 2012501410 A JP2012501410 A JP 2012501410A JP 2012501410 A JP2012501410 A JP 2012501410A JP 2012521404 A5 JP2012521404 A5 JP 2012521404A5
Authority
JP
Japan
Prior art keywords
los
composition
composition according
item
motomeko
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012501410A
Other languages
English (en)
Japanese (ja)
Other versions
JP5806204B2 (ja
JP2012521404A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/000735 external-priority patent/WO2010109325A2/en
Publication of JP2012521404A publication Critical patent/JP2012521404A/ja
Publication of JP2012521404A5 publication Critical patent/JP2012521404A5/ja
Application granted granted Critical
Publication of JP5806204B2 publication Critical patent/JP5806204B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012501410A 2009-03-24 2010-03-24 肺炎球菌血清型14の糖を含む組み合わせ Expired - Fee Related JP5806204B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16299609P 2009-03-24 2009-03-24
US61/162,996 2009-03-24
PCT/IB2010/000735 WO2010109325A2 (en) 2009-03-24 2010-03-24 Combinations including pneumococcal serotype 14 saccharide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015121897A Division JP2015163651A (ja) 2009-03-24 2015-06-17 肺炎球菌血清型14の糖を含む組み合わせ

Publications (3)

Publication Number Publication Date
JP2012521404A JP2012521404A (ja) 2012-09-13
JP2012521404A5 true JP2012521404A5 (enExample) 2013-05-09
JP5806204B2 JP5806204B2 (ja) 2015-11-10

Family

ID=42352288

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012501410A Expired - Fee Related JP5806204B2 (ja) 2009-03-24 2010-03-24 肺炎球菌血清型14の糖を含む組み合わせ
JP2015121897A Ceased JP2015163651A (ja) 2009-03-24 2015-06-17 肺炎球菌血清型14の糖を含む組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015121897A Ceased JP2015163651A (ja) 2009-03-24 2015-06-17 肺炎球菌血清型14の糖を含む組み合わせ

Country Status (9)

Country Link
US (1) US20120064104A1 (enExample)
EP (1) EP2411044A2 (enExample)
JP (2) JP5806204B2 (enExample)
CN (1) CN102421449A (enExample)
AU (1) AU2010227221B2 (enExample)
CA (1) CA2756398A1 (enExample)
NZ (1) NZ595223A (enExample)
RU (2) RU2549438C2 (enExample)
WO (1) WO2010109325A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258851A1 (en) 1999-05-19 2010-12-08 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
AR086405A1 (es) 2011-05-17 2013-12-11 Glaxosmithkline Biolog Sa Vacuna de streptococcus pneumoniae
US9427476B2 (en) 2012-05-24 2016-08-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Multivalent meningococcal conjugates and methods for preparing conjugates
NZ630133A (en) * 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
CA2875391A1 (en) 2012-07-27 2014-01-30 Institut National De La Sante Et De La Recherche Medicale Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
CA2937186C (en) * 2014-01-21 2022-11-01 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2015183676A1 (en) * 2014-05-29 2015-12-03 Kapre Subhash V Synthetic peptides as carriers for conjugation with polysaccharides
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2023132795A2 (en) * 2022-01-05 2023-07-13 National University Of Singapore Modified bacterial glycans and conjugates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587398A (en) * 2002-08-02 2012-03-30 Glaxosmithkline Biolog Sa Neisserial bleb preparations and vaccines comprising them
HUE032903T2 (hu) * 2005-12-22 2017-11-28 Glaxosmithkline Biologicals Sa Streptococcus pneumoniae kapszulárispoliszacharid-konjugátumok

Similar Documents

Publication Publication Date Title
JP2012521404A5 (enExample)
Barel et al. Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
Costantino et al. The design of semi-synthetic and synthetic glycoconjugate vaccines
JP2023036953A (ja) 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
RU2014122163A (ru) Комбинации, включающие сахарид пневмококка серотипа 14
RU2011142774A (ru) Комбинации менингококкового фактор н-связывающего белка и пневмококковых сахаридных конъюгатов
JP2007507487A5 (enExample)
JP2020533442A (ja) 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
JP2020533439A (ja) 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
RU2012149618A (ru) Менингококковые полипептиды fhbp
JP2011042693A5 (enExample)
TR201811681T4 (tr) İmmünojenik bileşimler.
US6132723A (en) Immunogenic oligosaccharide compositions
RU2005119640A (ru) Множественные варианты менингококкового белка nmbi1870
JP2014503172A5 (enExample)
BR112014018815B1 (pt) Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis
BE1024465A1 (fr) Vaccin
Sanders et al. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines
US5695768A (en) Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
US20020119162A1 (en) Synthetic vaccine agents
JP2015532276A (ja) 非直鎖状糖コンジュゲート
EP3544637B1 (en) Native omv-antigen conjugates and use thereof
JP2006528936A5 (enExample)
JP2012524099A5 (enExample)
US20040191264A1 (en) Synthetic vaccine agents